- Received October 03, 2024
- Accepted November 08, 2024
- Publication December 13, 2024
- Visibility 7 Views
- Downloads 0 Downloads
- DOI 10.18231/j.jdpo.2024.052
-
CrossMark
- Citation
Choriocarcinoma induced thyrotoxicosis
Introduction
Choriocarcinoma is a malignant disease arising from the placenta and trophoblastic villi. Gestational trophoblastic neoplasia (GTN) occur in 1 : 40,000 pregnancies and are more common in South East Asia as compared to Europe and North America.
Invasive mole and Choriocarcinoma are the most common GTN, producing high levels of HCG and are known to be responsive to chemotherapy.
HCG is used as a marker for diagnosis, monitoring the therapy and follow up of these patients. HCG is a glycoprotein produced by placenta and has an intrinsic thyroid stimulating activity. [1] Structural resemblance of TSH and HCG causes release of Thyroxine from the thyroid gland.
The first case of Hydatidiform mole and Thyrotoxicosis was reported in 1955 by Tisne and colleagues. [2]
Since then several cases of Gestational trophoblastic disease induced Hyperthyroidism have been reported in literature. [3], [4], [5], [6], [7], [8]
Case Presentation
A 25 year old female, diagnosed case of GTN (Choriocarcinoma) was admitted to our tertiary cancer care centre for chemotherapy and supportive care.
Case history
Patient was G2P0A1 (Obstretic score). She had history of one abortion more than a year back. No other details were available. She presented to us with complaints of pain in abdomen, bleeding per vaginum (PV) and breathlessness.
General examination
General condition was moderate.
Patient was afebrile.
Pulse 142/min, BP 110/70,
Respiratory rate 20/min,
SpO2 98 % on room air.
Systemic examination
Cardiovascular(CVS) and Central Nervous System(CNS) examination were normal.
Radiological investigations
Revealed extensive bilateral metastatic nodules in lung Parenchyma ([Figure 1]).
PET CT revealed hypermetabolic, heterogeneously enhancing solid cystic mass lesion involving the uterus and cervix. (Site of primary malignancy) ([Figure 1]).
CT Brain
Normal. No evidence of metastasis.
Blood Investigations revealed: ([Table 3])
Serum Beta-HCG level was 6,88,748 mIu/ml (Normal range: 0 to 10 mIu/ml).
Thyroid function tests showed Serum T3 to be 6.30 nmol/l (Normal range: 0.92 to 2.33 nmol/l).
Serum T4 was 975 nmol/l (Normal range: 62 to 120 nmol/l).
Serum TSH was less than 0.25 uIu/ml (Normal range: 0.25 to 5.00 uIu/ml).
Other Haematological and Biochemical parameters like Complete Blood Count(CBC), Kidney function tests (KFT) and liver function tests (LFT) were all within normal limits.
Diagnosis
|
Prognostic Factor |
Risk Score |
|||
|
0 |
1 |
2 |
4 |
|
|
Age ( Yrs) |
< 40 |
≥ 40 |
- |
- |
|
Antecedent pregnancy |
Hydatidi form mole |
Abortion |
Term Pregnancy |
|
|
Interval from Index Pregnancy ( months) |
< 4 |
4 to 6 |
7 to 12 |
> 12 |
|
Pretreatment HCG levels Iu/l |
< 103 |
103 to < 104 |
104 to 105 |
≥ 105 |
|
Largest tumor size including uterus ( cm ) |
< 3 |
3 to 5 |
> 5 |
- |
|
Site of Metasteses |
Lung |
Spleen,Kidney |
GIT |
Brain,Liver |
|
No. of metastases identified |
0 |
1 to 4 |
5 to 8 |
> 8 |
|
Previous Failed chemotherapy |
- |
- |
Single drug |
Two or more drugs |
|
Total Score |
12 |
|
Temperature (℉) |
Cardiovascular dysfunction |
||
|
99-99.9 |
5 points |
Tachycardia (beats/min) |
|
|
100-100.9 |
10 |
99-109 |
5 |
|
101-101.9 |
15 |
110-119 |
10 |
|
102-102.9 |
20 |
120-129 |
15 |
|
103-103.9 |
25 |
130-139 |
20 |
|
≥104.0 |
30 |
≥140 |
25 |
|
Atrial fibrillation |
10 |
||
|
Central Nervous System effects |
Heart Failure |
||
|
Absent |
0 |
Mild (pedal edema) |
5 |
|
Mild(agitation) |
10 |
Moderate (bibasilar rales) |
10 |
|
Moderate( delirium, psychosis, extreme lethargy) |
20 |
Severe (pulmonary edema) |
15 |
|
Severe (seizure, coma) |
30 |
||
|
Gastrointestinal-hepatic dysfunction |
Precipitant history |
||
|
Moderate( diarrhea, nausea/vomiting, abdominal pain) |
10 |
Positive |
0 |
|
Severe (unexplained jaundice) |
20 |
Negative |
10 |
|
Total: <25, storm unlikely, 25-45, impending storm, >45, thyroid storm |
Patients Score 35 –Impending thyroid storm ([Table 2])
Final Diagnosis: Gestational trophoblastic neoplasm (Chorio carcinoma, High Risk FIGO grade III).
([Table 1]) with pulmonary metastases and hyperthyroidism (Impending Thyroid storm) ( [Table 2]).
Treatment aspect
Chemotherapy was started: EMACO Day 1 and Day 8, 6 cycles.
Patient had Biochemical as well as Clinical Hyperthyroidism. Burch- Wartofsky score for patient was 35 which indicated impending thyroid storm. ([Table 2])
Patient was put on Neomercazol 5 mg BD. Other supportive care was initiated.
Patients Beta-HCG levels were monitored weekly. There was marked decline in serum BHCG levels. At one month, Beta-HCG was 711 mIu/ml and Thyroid function normalized. T3 was 2.0 nmol/l, T4 was 101 nmol/l and TSH was 1.80 uIu/ml. ([Table 3])
Patient’s Anti thyroid medication i.e Neomercazol was stopped. Patient was monitored on monthly basis for serum B HCG levels. At one year follow up, Patients Beta-HCG level was 0.3 mIu/ml.
Patient was Euthyroid without any anti thyroid medication and doing well.
|
Test |
Ref.Value s |
At presentation |
One month |
Six months |
One year |
|
B-HCG |
0 to 10 mIu/ml |
6,88,748 |
711 |
130 |
0.3 |
|
TSH |
0.25 to 5.00 uIu/ml |
Less than 0.25 |
1.80 |
|
1.14 |
|
T3 |
0.92 to 2.33 nmol/l |
6.30 |
2.00 |
|
1.2 |
|
T4 |
62 to 120 nmol/l |
975 |
101 |
|
66 |
|
F T3 |
2.30 to 4.20 pg/ml |
|
|
|
3.26 |
|
F T4 |
0.89 to 1.76 ng/dl |
|
|
|
0.81 |
|
Neomercazole |
|
Neomercazol e 5 mg BD |
Neomarcazol e 5mg BD |
Without Neomercazol e |
Without Neomercazol e |
Discussion
Choriocarcinoma is the most aggressive form of GTN, characterized by vascular invasion and wide spread metastases. The most common metastatic sites are lung (80 % ), vagina ( 30 % ) brain ( 10 % ) and liver ( 10 % ). [9]
The pathophysiology of thyroid disease in GTN is related to the secretion of HCG from the trophoblastic tissue. The effect of HCG on thyroid gland is thought to occur due to molecular mimicry between HCG and TSH.
The two known mechanisms are increased thyrotropic activity by HCG and structural resemblance with TSH causing release of thyroxine from thyroid gland. [10]
Cave and colleagues[11] examined serum from patients with metastatic choriocarcinoma. By using gel filtration, a single peak coinciding with HCG was demonstrated. This suggested that the thyrotropin of choriocarcinoma was HCG. The similarity in structure between HCG and TSH can cause cross reactivity of each receptor.
Various studies have shown prevalence of hyperthyroidism with high levels of HCG. Lockwood et al. found suppressed TSH in 100 % specimen with HCG concentration > 40,000 Iu/l. [12] Glinoer estimated that any increase 10,000 Iu/l for HCG will be followed by increase in FT4 by
ng/dl and reduction in TSH by 0.1 mIu/ml. [13], [14], [15]
Although there is no precise threshold at which HCG causes Thyrotoxicosis, thyroid function should be measured in all patients with HCG > 50,000 Iu/L regardless of the cause of elevation. [16], [17]
Choriocarcinoma is sensitive to chemotherapy and choice of regimen is based on WHO (World Health Organisation)Prognostic Scoring System and the International Federation of Gynecology and Obstetrics( FIGO) anatomic staging system.
In patients having Biochemical and Clinical Hyperthyroidism, Burch- Wartofsky score should be assessed for presence of Thyroid storm and treatment should be initiated accordingly. Unless there are symptoms of severe thyrotoxicosis, treatment of hyperthyroidism is not needed, as chemotherapy for Choriocarcinoma should effectively bring down the HCG levels alleviating the hyperthyroidism.
Conclusion
Choriocarcinoma is not only associated with Hyperthyroidism , but also can induce thyroid storm.
GTD induced thyroid storm should be considered in any female of child bearing age with signs and symptoms of Thyrotoxicosis.
High levels of HCG are directly proportional to the clinical manifestation of Hyperthyroidism.
Thyroid function must be measured in all patients with HCG levels > 50,000Iu/L.
In patients having Biochemical and clinical hyperthyroidism, Burch- Wartofsky score should be assessed for presence of Thyroid storm and treatment should be initiated accordingly.
Unless there are symptoms of severe thyrotoxicosis, Treatment of hyperthyroidism is not initiated.
Thyroid function is expected to return to normal once the HCG levels come down.
Awareness of this condition is important for diagnosis and treatment of GTD.
GTD induced thyroid storm should be considered in any female of child bearing age with signs and symptoms of thyrotoxicosis.
Source of Funding
None.
Conflict of Interest
None.
References
- HJ Clain, PR Pannall, D Kotasek, RJ Norman. Choriogonadotropin-mediated thyrotoxicosis in a man. Clin Chem 1991. [Google Scholar]
- L Tisne, J Barzelatto, C Stevenson. Estudio de function tireoldeaduranteelestado gravid- puerperalconelyodoradioactivo. Bot S 1955. [Google Scholar]
- BC Nisula, GS Taliadouros. Thyroid function in gestational tropho- blastic neoplasia: Evidence that the thyrotropic activity of chorionic gona- dotropin mediates the thyrotoxicosis of choriocarcinoma. Am J Obstet Gynecol 1980. [Google Scholar]
- WP Myers. An analysis of medical problems in cancer. Med Clin North Am 1961. [Google Scholar]
- JD Cohen, RD Utiger. Metastatic choriocarcinoma associated with hyperthyroidism. J Clin Endocrinol Metab 1970. [Google Scholar]
- JE Morley, RJ Jacobson, J Melamed, JM Hershman. Choriocarcinoma as a cause of thyrotoxicosis. Am J Med 1976. [Google Scholar]
- WD Odell, RW Bates, RS Rivlin. Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma. J Clin Endocrinol Metab 1963. [Google Scholar]
- K Miyai, O Tanizawa, T Yamoto, M Azukizawa, Y Kawai. Pituitary-thyroid function in trophoblastic disease. J Clin Endocrinol Metab 1976. [Google Scholar]
- G Zanetta, R Maggi, M Colombo, G Bratina, C Mangioni. Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literature. Int J Gynecol Cancer 1997. [Google Scholar]
- JVB Pereira, T Lim. Hyperthyroidism in gestational trophoblastic disease-a literature review. Thyroid Res 2021. [Google Scholar]
- WT Cave, JT Dunn. Choriocarcinoma with hyperthyroidism: Probable identity of the thyrotropin with human chorionic gonadotropin. Ann Intern Med 1976. [Google Scholar]
- CM Lockwood, DG Grenache, AM Gronowski. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid 2009. [Google Scholar]
- DS Cooper, LE Braverman. . Trophoblastic tumor in Werner Ingbar's. The thyroid: A fundamental and clinical text 2013. [Google Scholar]
- Lhf Meister, PR Hauck, H Graf, GA Carvalho. Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma. Arq Bras Endocrinol Metabol 2005. [Google Scholar]
- L Walkington, J Webster, BW Hancock, J Everard, RE Coleman. Hyperthyroidism and human chorionic gonadotropin in gestational trophoblastic disease. Br J Cancer 2011. [Google Scholar]
- SF Oosting, ECD Hass, TP Links, DD Bruin, WJ Sluiter, IJD Jong. Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol 2010. [Google Scholar]
- P Heda, G Cushing. Testicular choriocarcinoma presenting as hyperthyroidism. Am J Med 2013. [Google Scholar]